Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 2Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 187Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Hematologic Neoplasms 98Leukemia, Lymphocytic, Chronic, B-Cell 88Myelodysplastic Syndromes 72Leukemia 63Lymphoma 45Multiple Myeloma 40Lymphoma, Non-Hodgkin 36Leukemia, Myelogenous, Chronic, BCR-ABL Positive 35Burkitt Lymphoma 28Neoplasms 25Recurrence 23Leukemia, Myelomonocytic, Chronic 23Myeloproliferative Disorders 21Lymphoma, Large B-Cell, Diffuse 20Hodgkin Disease 20Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia, Biphenotypic, Acute 18Lymphoma, Mantle-Cell 17Leukemia, B-Cell 17Lymphoma, B-Cell 15Lymphoma, Follicular 14Waldenstrom Macroglobulinemia 13Anemia, Refractory, with Excess of Blasts 13Myelodysplastic-Myeloproliferative Diseases 11Lymphoma, B-Cell, Marginal Zone 11Leukemia, Hairy Cell 9Blast Crisis 9Primary Myelofibrosis 8

Interventions

obinutuzumab 1acalabrutinib 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphatic Diseases × Other hematologic neoplasm × 30 days × Clear all
NCT06651970 2026-05-18

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

AstraZeneca

Phase 4 Recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Heart Failure, Lymphatic Diseases, Leukemia, B-Cell

NCT01451502 2026-05-08

Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

Masonic Cancer Center, University of Minnesota

Phase NA Recruiting
250 enrolled
Other hematologic neoplasm

Lymphatic Diseases, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡